Two Sigma Advisers’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Two Sigma Advisers’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-157	Closed	-$3K	–	2761
2022 Q2	$3K	Sell	157 -228	-59%	-$5.71K	﹤0.01%	2615
2022 Q1	$14K	Sell	385 -59	-13%	-$2.12K	﹤0.01%	2683
2021 Q4	$16K	Buy	+444	New	+$23.4K	﹤0.01%	2555
2021 Q1	–	Sell	-1,855	Closed	-$79K	–	2755
2020 Q4	$79K	Buy	1,855 +288	+18%	+$10.7K	﹤0.01%	2288
2020 Q3	$55K	Buy	+1,567	New	+$69.4K	﹤0.01%	2321
2019 Q4	–	Sell	-116	Closed	-$12K	–	2497
2019 Q3	$12K	Sell	116 -1	-0.9%	-$217	﹤0.01%	2192
2019 Q2	$35K	Buy	+117	New	+$41.2K	﹤0.01%	2270
2015 Q4	–	Sell	-3	Closed	-$3K	–	2047
2015 Q3	$3K	Buy	+3	New	+$4.37K	﹤0.01%	1783

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers's CSCI Position: Q3 2022 in Review

Two Sigma Advisers sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 157 shares — an estimated $3K sold.

Two Sigma Advisers first reported a position in CSCI in Q3 2015 and held it in 8 quarters. The position peaked at $79K in Q4 2020. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Two Sigma Advisers reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Two Sigma Advisers sold 157 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $3K.
Two Sigma Advisers first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2015 and held it in 8 quarters.
Two Sigma Advisers's COSCIENS Biopharma Inc. Common Stock position peaked at $79K in Q4 2020.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.